Skip to main content

Table 1 Clinicopathological features of the patients

From: Effect of preoperative PI-RADS assessment on pathological outcomes in patients who underwent radical prostatectomy

Variables

Overall cohort (n = 380)

PI-RADS

(n = 201)

Non-PI-RADS

(n = 179)

p

Preoperative

Age (year)*

66 (62–70)

67 (63–70)

65 (61–70)

0.085

 

PSA (ng/mL)

   

0.062

 

 ≤ 10

205 (53.9)

118 (58.7)

87 (48.6)

 
 

 > 10

175 (46.1)

83 (41.3)

92 (51.4)

 
 

Clinical T stage

   

< 0.001

 

 cT1-2

342 (90.0)

170 (84.6)

172 (96.1)

 
 

 cT3

38 (10.0)

31 (15.4)

7 (3.9)

 
 

ISUP grade

    
 

 1

116 (30.5)

62 (31.0)

54 (30.2)

0.187

 

 2

94 (24.7)

54 (27.0)

40 (22.3)

 
 

 3

76 (20.0)

44 (22.0)

32 (17.9)

 
 

 ≥ 4

94 (24.7)

41 (20.0)

53 (29.6)

 
 

Surgical experience

   

0.954

 

 < 100

268 (70.5)

141 (70.1)

127 (70.9)

 
 

 ≥ 100

112 (29.5)

60 (29.9)

52 (29.1)

 
 

PI-RADS

    
 

 2

 

6 (3.0)

  
 

 3

 

28 (13.9)

  
 

 4

 

102 (50.7)

  
 

 5

 

65 (32.3)

  
 

Indication of suspicious lesions

345 (93.1)

195 (97.0)

150 (83.8)

< 0.001

 

Correct preoperative staging

275 (72.3)

159 (79.1)

116 (64.8)

0.003

Postoperative

Pathological T stage

   

< 0.001

 

 pT2

269 (70.8)

158 (78.6)

111 (62.0)

 
 

 pT3-4

111 (29.2)

43 (21.4)

68 (48.0)

 
 

Upstaging

89 (23.4)

27 (13.4)

62 (34.6)

< 0.001

 

PSM

136 (35.8)

63 (31.3)

73 (40.9)

0.055

  1. Note—Unless otherwise indicated, data are number (percentages). PSA = prostate-specific antigen; ISUP = international society of urological pathology; PSM = positive surgical margin; PI-RADS = Prostate Imaging-Reporting and Data System
  2. * Data are median (interquartile range [IQR])